InvestorsHub Logo
Followers 1
Posts 120
Boards Moderated 0
Alias Born 08/24/2017

Re: None

Wednesday, 03/07/2018 5:01:54 PM

Wednesday, March 07, 2018 5:01:54 PM

Post# of 41173
Since we're talking about valuations what about the potential AMDA has on it's own. Since many here take the position that most, if not all, of the business they've done so far has been mostly market testing stuff what can they actually accomplish on their own now that they have this approval? If they've added 14 new sales reps in 2017, 40% increase in surgeon practice, "over 33,000 silicon nitride spinal interbody implants implanted since 2008" 5000 of those in 2017 which may have contributed to around $10 million to earnings. If AMDA did around $20 million for 2017 who is to say they can't double that this year and with a multiple of like 5 wouldn't that be already around $200 million? And I know they are going to need money to grow, which would mean loans or dilution or whatever, but am I way off here? So I know that amount would be way undervalued but still around a $30 share price right? some posters are making it seem like AMDA is fairly valued at 6 million market cap.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News